This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

WILLIAM NEEDLES, M.D.

Arch Intern Med. 1936;58(5):765-772.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Nine years has elapsed since Minot and Murphy discovered the value of liver therapy for pernicious anemia. This period of time appears sufficiently long to allow a fair evaluation of the results achieved. But while this may hold true for the hematologic phase of the disease, there is considerable diversity of opinion concerning the neurologic aspects. This relates to two distinct questions: one is whether neurologic complications, once they have arisen, can be ameliorated or made to disappear by means of liver therapy; the other is whether adequate therapy can prevent the onset of neurologic complications in a patient not as yet affected.

In a previous study¹ I reported some observations bearing on the first problem. The findings indicated that in cases of advanced subacute combined degeneration treatment with liver had negligible effects. These findings appeared in conformity with what one would anticipate from a knowledge of the underlying . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

From the Neurological Service, Dr. Israel Strauss, Attending Neurologist, and the Hematology Clinic, Dr. Nathan Rosenthal, Hematologist, of the Mount Sinai Hospital.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?